Frontier Capital Management CO LLC Chemo Centryx, Inc. Transaction History

Frontier Capital Management CO LLC

  • $9.96 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$46.35 - $61.69 $597,822 - $795,677
-12,898 Closed
0 $0
Q2 2020

Jul 17, 2020
SELL
$38.58 - $65.07 $655 - $1,106
-17 Reduced 0.13%
12,898 $742,000
Q1 2020

Apr 16, 2020
SELL
$32.73 - $50.78 $4.52 Million - $7.02 Million
-138,229 Reduced 91.46%
12,915 $519,000
Q4 2019

Feb 14, 2020
BUY
$6.81 - $39.55 $1.03 Million - $5.98 Million
151,144 New
151,144 $5.98 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email